Filter Results
:
(90)
Show Results For
-
All HBS Web
(576)
- Faculty Publications (90)
Show Results For
-
All HBS Web
(576)
- Faculty Publications (90)
cancer →
←
Page 5 of
90
Results
- December 2003
- Case
Manville Corporation Fiber Glass Group (C) (Abridged)
By: Lynn S. Paine
Manville Corp.'s senior managers are surprised when Japanese government officials advise them not to go forward with their plan to add a cancer warning label to diatomaceous earth (DE) products sold in Japan. The International Agency for Research on Cancer has ruled...
View Details
Keywords:
Risk and Uncertainty;
Moral Sensibility;
Safety;
Government Administration;
Cross-Cultural and Cross-Border Issues;
Decision Choices and Conditions;
Ethics;
Announcements;
Industrial Products Industry;
Japan
Paine, Lynn S. "Manville Corporation Fiber Glass Group (C) (Abridged)." Harvard Business School Case 304-078, December 2003.
- April 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (A)
By: Sandra J. Sucher and Stacy McManus
Preliminary results from Phase 1 clinical trials of a newly developed compound, STI571, showed that 31 out of 31 patients with chronic myelogenous leukemia (CML) had their blood counts return to normal. In the world of oncology, this was unheard of. This was the...
View Details
Keywords:
Decision Making;
Health Testing and Trials;
Innovation and Invention;
Markets;
Distribution;
Product Development;
Production;
Problems and Challenges;
Research;
Research and Development;
Complexity;
Biotechnology Industry;
Pharmaceutical Industry
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (A)." Harvard Business School Case 603-043, April 2003. (Revised October 2004.)
- August 2001 (Revised August 2012)
- Case
BestDoctors, Inc.
By: Regina E. Herzlinger and Seth Bokser
Upon learning the news of a critical illness, patients and their families are shocked, saddened, fearful, and angry all at once. And just as soon as they catch their collective breath, they all ask the same question—a question that has the potential to infuse hope into...
View Details
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to...
View Details
Keywords:
Product Development;
Marketing Strategy;
Health Testing and Trials;
Risk and Uncertainty;
Technological Innovation;
Innovation Strategy;
Science-Based Business;
Biotechnology Industry
Dolan, Robert J. "Abgenix and the XenoMouse." Harvard Business School Case 501-061, January 2001.
- August 1999
- Teaching Note
Dana-Farber Cancer Institute: Development Strategy, The (TN)
Teaching Note for (9-599-104).
View Details
- May 1999 (Revised December 2007)
- Case
The Dana-Farber Cancer Institute: Development Strategy
By: V. Kasturi Rangan and Marie Bell
Despite revenues in excess of $93 million in 1998, world-renowned Dana-Farber Cancer Institute constantly faces an operating shortfall and looks to its highly successful development office to help cover the deficit. The development office raises money annually (with a...
View Details
Keywords:
Decision Choices and Conditions;
Capital;
Revenue;
Growth and Development Strategy;
Mission and Purpose;
Nonprofit Organizations
Rangan, V. Kasturi, and Marie Bell. "The Dana-Farber Cancer Institute: Development Strategy." Harvard Business School Case 599-104, May 1999. (Revised December 2007.)
- February 1994 (Revised May 1999)
- Case
Manville Corp. Fiber Glass Group (C)
By: Lynn S. Paine and Sarah Gant
Manville Corp.'s senior managers are surprised when Japanese government officials advise them not to go forward with their plan to add a cancer warning label to diatomaceous earth (DE) products sold in Japan. The International Agency for Research on Cancer has ruled...
View Details
Keywords:
Management Teams;
Ethics;
Conflict of Interests;
Health;
Safety;
Cross-Cultural and Cross-Border Issues;
Policy;
Japan
Paine, Lynn S., and Sarah Gant. "Manville Corp. Fiber Glass Group (C)." Harvard Business School Case 394-116, February 1994. (Revised May 1999.)
- September 1992 (Revised October 1992)
- Case
Massachusetts General Hospital: Cancer Research Center
By: Ray A. Goldberg and Eve Stacey
Goldberg, Ray A., and Eve Stacey. "Massachusetts General Hospital: Cancer Research Center." Harvard Business School Case 593-029, September 1992. (Revised October 1992.)
- Research Summary
Mastering Strategy Execution
By: Robert Simons
Professor Robert Simons’ research encompasses three areas of management accountability that are the foundation for successful strategy execution: organization design, performance measurement and control, and risk management. In addition, Simons is interested in the... View Details
- Research Summary
Negotiating in the Shadow of Cancer
By: Deepak Malhotra
I am working with collaborators at the Memorial Sloan Kettering Cancer Center to develop interventions that will help surgeons communicate more effectively with cancer patients, with the goal of helping patients make better decisions regarding their health.
View Details